Edward Cox Email and Phone Number
Edward Cox work email
- Valid
- Valid
- Valid
- Valid
Edward Cox personal email
Edward Cox phone numbers
Edward Cox is an innovative, inspiring, and relentless life science and digital health executive. With a background in executive leadership, pharma, tech, investment banking, and public markets, he is uniquely positioned to lead digital health companies through fundraising, strategic partnering, FDA approval, and exit. From 2020 to 2022 Edward Cox was the Executive Vice President of Strategic Alliances & Global Head of Digital Medicine at EVERSANA.Edward Cox was appointed Chief Executive Officer and a member of the Board of Directors of Dthera Sciences in September 2016. Mr. Cox previously served as EveryStory’s Chief Executive Officer and a member of EveryStory’s Board of Directors, beginning in 2015. Prior to that he served as a Vice President and Executive Officer of Apricus Biosciences, Inc., a NASDAQ company, beginning in 2009, in roles leading Commercial Development, Business Development, Investor Relations, and Corporate Development. Mr. Cox served as the President, Director and Secretary of Bio-Quant, Inc. from 2007 until BioQuant’s merger with NexMed, Inc., which was renamed Apricus Biosciences. Prior to 2007, Mr. Cox served as an executive or board member of both public and private companies in the areas of Healthcare, Life Science, Technology and Resources.
Pfizer
View- Website:
- pfizer.com
- Employees:
- 100690
-
Head And General Manager Of Digital Health And Medicines (Dhm)PfizerSan Diego, Ca, Us
-
Head & General Manager Of Digital Health & Medicines (Dhm)Pfizer 2022 - PresentNew York, New York, UsI am so honored and excited to announce that I have started a new role as the Head & General Manager of Digital Health & Medicines (DHM) at Pfizer. This is a transformational time for the fields of Digital Health, Digital Medicines, and Digital Therapeutics and I am grateful to have the chance to create and shape the fields’ new futures by collaborating with so many amazing colleagues.
-
Board MemberDecentralized Trials & Research Alliance (Dtra) 2020 - PresentThe 501(c)(3) non-profit - Decentralized Trials & Research Alliance (DTRA) - was convened to enable collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research. It works to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research methods. -
Leadership CouncilCns Summit 2017 - PresentBoston, Ma, UsCNS Summit was created by life science leaders to advance clinical development, with a focus on collaboration, innovation, and technology. The CNS Summit is a community of innovators and industry leaders and the 2020 CNS Summit convenes 1000+ decision-makers from organizations involved in clinical development, healthcare innovation, regulatory authorities, investigator sites, and service companies. -
Executive Vice President Strategic Alliances & Global Head Of Digital MedicineEversana 2020 - 2022Chicago, Il, UsEd Cox led EVERSANA's Global Practice of Digital Medicine directly impacting the two critical questions facing the fields of Digital Medicine and Digital Therapeutics: how can companies directly commercialize these products, and how can pharmaceutical companies effectively deploy digital therapies into their product portfolios to maximize the value and impact. -
Guest LecturerSeton Hall University 2020 - 2022South Orange, Nj, Us -
Guest LecturerCornell Tech 2021 - 2021New York, Ny, Us -
Guest LecturerUsc School Of Pharmacy 2020 - 2021Los Angeles, Ca, Us -
CeoDthera Sciences 2015 - 2020San Diego, California, UsDthera Sciences was a leading digital therapeutic company specializing in neurodegenerative diseases. • Led company from startup to a company that was consistently mentioned among the top 5 companies in the digital therapeutics sector• Dthera’s core product, DTHR-ALZ, was a digital therapeutic that digitally delivered an evidence-based therapy called Reminiscence Therapy to Alzheimer’s patients• First Digital Therapeutic to receive Breakthrough Device designation from the FDA as a Mono-therapy and the first for the treatment of Alzheimer's disease or symptoms• If it had received FDA approval, it would have become the first non-pharmacological prescription treatment and first medical device of any kind for the treatment of Alzheimer's diseaseEveryStory, Inc. (became Dthera Sciences) 2015-2016• Interactive cloud based social media platform, combining photo and audio sharing technologies designed to consolidate and archive families’ precious memories for future generations• Acquired by Dthera Sciences in 2016 -
Vice President Of Commercial DevelopmentApricus Biosciences, Inc. 2014 - 2014NASDAQ-listed pharmaceutical company focused on men's and women's health• Focused on launch of Vitaros in multiple countries through multiple partners throughout Europe and North American including: UK, Germany, France, and Canada among others• Drove the process in the lead up to product launches via multiple partners. • Apricus’s value grew from $15M prior to the time of the merger to more than $75M in market cap on the NASDAQ by the time he left in 2014
-
Vice President Of Global Business DevelopmentApricus Biosciences, Inc. 2013 - 2014• Ran a comprehensive out-licensing process for Vitaros, contacting nearly 100 companies, with multiple offers received. Vitaros is being commercialized by marketing partners.• Managed primary partnership agreements and licensing with global partners, including Abbott Laboratories, Laboratoires Majorelle, Recordati, Sandoz (a subsidiary of Novartis), and Takeda Pharmaceuticals• Managed M&A activities leading to divestiture of two subsidiaries: Topotarget USA (oncology supportive care operating company) and Scomedica (French pharmaceutical sales force)
-
Vice President Of Corporate Development & Investor RelationsApricus Biosciences, Inc. 2010 - 2013• Took the company from $15M, with $1M cash on hand, to market cap of over $75M and $15M cash on the balance sheet through a comprehensive Investor Relations program with successful marketing outreach• Led multiple rounds of financings: o $18M with Lazard, February 2012 o $10M with Brinson Patrick Securities Corporation, December 2011 o $10M of later exercised warrants with Dawson James, October 4, 2010• Divested Bio-Quant Inc. to BioTox (now BTS Research) in June 2011
-
President & Board DirectorBio-Quant, Inc (Acquired By Apricus Biosciences) 2007 - 2010• Led the successful merger with NexMed (NEXM) in December 2009• Bio-Quant ($12M) and NexMed ($15M) merger led to the organizational branding as NexMed, with a combined entity value of $27M• Managed non-scientific operations of company with $5M in annual revenues and 30+ employees, established operational and financial systems and excellence
Edward Cox Skills
Edward Cox Education Details
-
University Of FloridaTelecommunication -
University Of Florida - Warrington College Of BusinessManagement
Frequently Asked Questions about Edward Cox
What company does Edward Cox work for?
Edward Cox works for Pfizer
What is Edward Cox's role at the current company?
Edward Cox's current role is Head and General Manager of Digital Health and Medicines (DHM).
What is Edward Cox's email address?
Edward Cox's email address is ed****@****ana.com
What is Edward Cox's direct phone number?
Edward Cox's direct phone number is +185860*****
What schools did Edward Cox attend?
Edward Cox attended University Of Florida, University Of Florida - Warrington College Of Business.
What skills is Edward Cox known for?
Edward Cox has skills like Mergers And Acquisitions, Start Ups, Biotechnology, Corporate Development, Commercialization, Pharmaceutical Industry, Venture Capital, Business Strategy, Business Development, Strategic Planning, Due Diligence, Licensing.
Who are Edward Cox's colleagues?
Edward Cox's colleagues are Patricia Canaveris, Andy Roberts, Carolyn Simmons, Abhay Sonone, Dhanya Bhat, Julia Zuzolo, Mike Julien.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial